Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease, which has caused serious social and economic burden. The main characteristic of COPD is the heterogeneity of disease, manifesting as emphysema, functional small airways disease (fSAD) and large airway diseases. Imaging plays an important role in the evaluation of COPD. In this article, we summarized the recent advances in the imaging of COPD, especially in the quantitative and functional evaluations of the disease. Imaging provides the detailed anatomical, quantitative and function information, illustrates regional heterogeneity and spatial distribution, as well as provides microstructural assessment on the alveolar level. Especially, air trapping index (ATI), parametric response mapping (PRM), gas exchange and texture analysis facilitate the early diagnosis, phenotype classification, severity and therapeutic effect evaluation.
Introduction
Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases [1] . COPD is the third cause of worldwide death, accounting for the one-third of death in China [2] , which has caused serious social and economic burden. The main characteristic of COPD is the heterogeneity of disease, manifesting as emphysema, functional small airways disease (fSAD) and large airway diseases. Moreover, emphysema and fSAD usually coexist. How to differentiate the emphysema from fSAD is very important to improve the classification of phenotypes, instruct the individualized therapy and improve the prognosis. Pulmonary function test (PFT) is the clinical established approach for the diagnosis of COPD. The diagnosis is based on spirometry, a ratio of forced expiratory volume in the first second (FEV1)/forced vital capacity (FVC) is less than 70% (FEV1/FVC < 70%), and FEV1 increases less than 200 ml after the use of a bronchodilator [3] . However, PFT reflects the whole lung function change, which cannot reflect the regional change and is not sensitive to the early change of COPD.
Imaging plays an important role in the evaluation of COPD [4] : with the advent of CT in 1970s, pulmonary parenchyma and large airway were evaluated; in the following 30 years, CT lung density analysis was performed; since 2000s, the phenotype of COPD and airway quantitative analysis has been studied; and the latest CT-based and MRbased technologies make it possible to evaluate the morphological and functional change of COPD in the early stage. According to the dominancy of emphysema and the presence of bronchial wall thickening, COPD is classified into three phenotypes: A phenotype, no or mild emphysema with or without bronchial wall thickening; E phenotype, apparent emphysema without bronchial wall thickening; M phenotype, apparent emphysema with bronchial wall thickening 1 3 [5] . In this article, we summarized the progress in the imaging of COPD, especially on quantitative, functional evaluation and texture analysis.
Quantitative imaging
Quantitative evaluation of COPD mainly focuses on CT lung density, small airway and small pulmonary vessels, which can provide detailed anatomical and quantitative information.
Lung density analysis
In clinical routine work, chest CT is performed on the end of inspiration. According to the density of pulmonary parenchyma on inspiratory phase CT images, the pulmonary parenchyma is classified into 3 regions, E (emphysema) region (− 950 to − 1024 HU), H (hyperinflated) region (− 900 to − 949 HU) and N (normal) region (− 400 to − 899 HU) [6] . The pixel percentage of low-density region with attenuation less than − 950 HU is defined as LAA% − 950 or emphysema index (EI = TEV/TLV). It has been reported that healthy non-smokers showed emphysema-like change with EI > 0% [7] . However, the normal limit of EI among the healthy non-smokers varied from less than 1-6.8% in previous studies with different age ranges [7] [8] [9] [10] [11] . In the statement of the Fleischner society on CT-definable subtypes of COPD, the emphysema was defined as the pixels < − 950 HU more than 6% by CT quantitative evaluation [12] . It has been reported that TEV and EI were negatively correlated with FEV1/FVC [13] . At present, evaluation of lung density on the lobar level is possible, which evaluates the heterogeneity of COPD.
Air trapping is the retention of air in the lung distal to an obstruction (usually partial), which is seen on end-expiration CT scans manifesting as parenchymal areas with less than normal increase in attenuation and lack of volume reduction [14] . Detailed analysis of density change on inspiration and expiration CT of COPD can provide new insights into pulmonary functional impairment in each lung area. Paired inspiratory and expiratory phases could obtain more parameters, including expiratory to inspiratory ratio of mean lung density (E/I MLD), air trapping index (ATI), relative volume change − 856 to − 950 (RVC 856-950 ), expiratory − 856 (Exp-856) and parametric response mapping (PRM) (Fig. 1) . The expiration images were deformed to match the inspiration images per pixel with a non-rigid method, then subtraction was performed between inspiration and expiration CT images, and subtraction value per pixel was obtained. ATI is defined as the volume of voxels having a subtraction value lower than a threshold for air trapping [15] . The subtracted images could evaluate the heterogeneity of COPD comprehensively, including evaluation the air trapping in non-emphysema area. ATI, in compassion with EI, showed more significant correlation with PFT. Lee et al. found the optimal CT threshold of subtraction method for air trapping was 60 HU; ATI with 60 HU thresholds was comparable to E/I MLD and Exp-856 [15] . RVC is defined as the difference between the expiratory and inspiratory values for relative lung volumes, which is the limited lung volume with attenuation between − 856 and -950 HU. It has been proven that in COPD patients no matter with emphysema or not, RVC856-950 showed the most significant relation to emphysema [16] . Exp-856 is defined as the percent of the lung voxels with attenuation < − 856 HU on the expiratory CT images [17] . In the previous study with paired respiratory phases, Exp-856 was used to evaluate the air trapping, but could not differentiate the cause from emphysema or functional small airways disease (fSAD). fSAD is defined as non-emphysematous airflow obstruction [18, 19] . PRM is a postprocessing approach to evaluate fSAD, which is based on the voxel density change between inspiratory and expiratory CT. Boes [18] found fSAD was a transitional phase from normal parenchyma to emphysema. PRM combines the subjective and objective evaluation of COPD, and helps to assess the phenotype, severity, spatial heterogeneity, lung density changes and longitudinal surveillance. Based on topological techniques, Hoff [19] generated 3D maps of local topological features from 3D PRM fSAD classification maps and found that the surface area of fSAD (S fSAD ) was the most robust and significant independent indicator of clinically meaningful measures of COPD.
Besides, dynamic imaging evaluates the morphological and functional change during the whole respiratory cycle and the dynamic progression of disease. Respiratory gated chest 4D-CT allows for the morphological and functional information, providing new insights into functional impairment and individual treatment planning [20] .
Small airway quantitative analysis
Small airway remodeling is one of the major characteristics of COPD. Direct measurement of small airway is applied in the 6th or proximal generation of airways, including wall thickness (WT), wall area (WA), lumen area (LA), wall area percentage (WA%), and inner perimeter 10 mm (Pi10). Guan Y et al. found WA% of 6th order bronchus has a significant positive correlation with EI, indicating that the extent of distal bronchial wall thickening is more relevant with emphysema [21] . Previous studies focused on cross-sectional CT images of small airways. Oguma T was the first to assess the longitudinal structure of the airway lumen, and found longitudinal airway lumen shape irregularity was significantly greater in patients with COPD than patients with bronchial asthma and healthy controls [22] . Indirect measurement of small airway is to analyze ATI and PRM fSAD using paired inspiratory and expiratory scanning [6, 16, 18] . It has been reported that PRM fSAD was negatively correlated with total airway count (TAC) [23] , which was independently associated with lung function decline. TAC may reflect the airway-related disease changes that accumulate in the "quiet" zone in early/mild COPD, indicating that TAC may be a biomarker to predict the accelerated COPD progression [23] .
Small pulmonary vessels quantitative analysis
Small pulmonary vessels remodeling in COPD could be evaluated with the percentage of small pulmonary vessels (% cross-sectional area [CSA]), as a parameter of pulmonary perfusion, which correlates inversely with airflow limitation as well as with pulmonary hypertension and radiographic emphysema in COPD [24] . Takayanagi et al. found the WA% at the distal bronchi and the %CSA < 5 did not change in parallel with parameters of LAA over the same period, suggesting airway disease and vascular remodeling may be reversible to some extent by smoking cessation and appropriate treatment [25] . Therefore, in the early stage of COPD, we should pay more attention to the pulmonary vascularity and airway disease rather than parenchymal destruction. Moreover, CT measurements of small vessels support a distinct vessel-related phenotype in COPD patients with severe pulmonary hypertension (HP), combining %CSA < 5, PaO2 and WT best prediction of severe PH in patients with COPD [26] .
Functional imaging

Perfusion imaging
CT and MR perfusion imaging have been widely used in the assessment of focal pulmonary parenchyma perfusion in a variety of patients with pulmonary embolism, lung cancer and emphysema. Previous studies focused on the early diagnosis, severity assessment, phenotype classification, differential diagnosis of high-risk population from the mild COPD patients and correlation with PFT and CT quantitative parameters. Compared with CT, MR perfusion imaging shows higher potential to distinguish controls from mild COPD and appears more sensitive in identifying abnormalities among smokers with normal PFT [27] . CT and MRI perfusion parameters, such as positive enhancement integral (PEI), maximum slope of increase (MSI), maximum slope of decrease (MSD), signal enhancement ratio (SER), and signal intensity ratio (R SI ) of perfusion defects to normal lung, were positively correlated with PFT parameters; and negatively correlated with EI [5, 13, 28] .
Ventilation imaging
A series of ventilation imaging approaches have been used to evaluate the ventilation status of COPD, including the static imaging, dynamic imaging, hyperpolarized inert gas imaging, oxygen enhanced imaging and fluorinated gas imaging [29] [30] [31] [32] [33] ; which focused on subjective and semiquantitative evaluation, such as ventilation defect, homogeneity and so on. At present, objective and regional evaluation come true. Lobar ventilation and ADC values obtained from hyperpolarized 129Xe MR imaging demonstrated correlation with quantitative CT percentage emphysema on a lobar basis and with PFT results [34] . Capaldi et al. compared MR imaging and CT PRM measurements of gas trapping and emphysema in ex-smokers both with and without COPD, and found ventilation defect percent (VDP) was related to PRM gas trapping in patients with mild-to-moderate COPD, whereas in patients with severe COPD, VDP correlated with both PRM gas trapping and PRM emphysema [35] (Fig. 2) . It has been reported that xenon-enhanced dual-energy CT has been used to evaluate the regional emphysema, air trapping and xenon-ventilation abnormalities in COPD patients, and found the combination of attenuation and xenon can predict more accurate PFTs [36, 37] .
Gas exchange imaging
Diffusing capacity of the lungs for carbon monoxide (DLCO) is a direct marker of global gas exchange. Hyperpolarized (HP) 129Xe gas is liposoluble, and can transfer from alveoli to interstitial barrier tissues and capillary RBCs, transferring from the gas phase (GP) signal to the dissolved phase (DP) signal. Pulmonary interstitial barrier tissues are composed of alveolar epithelial cells, interstitial tissues, capillary endothelial cells, and plasma. Therefore, there are three compartments, including the alveoli (GP), pulmonary barrier tissues (TP) and capillary red blood cells (RBCs). The 129Xe spectrum exhibits three resonances in lung at 0 ppm, 198 ppm and 217 ppm corresponding to 129Xe in airspaces, dissolved in barrier and RBCs [30, 38] . TP/GP, RBC/GP, RBC/TP and DP/GP could quantify the alveolar capillary membrane thickness indirectly. Wang JM et al. found 129Xe MRI-derived barrier uptake, RBC transfer and RBC/barrier ratio correlated well with DLCO [38] . The direct regional gas exchange measurements are sensitive to [35] Ventilation and PRM in a 55-year-old man without COPD (FEV1, 83% of predicted value; FEV1/FVC, 77%; residual volume to total lung capacity ratio [RV/TLC], 45%), a 69-year-old man with GOLD I disease (FEV1, 89% of predicted value; FEV1/FVC, 69%; RV/TLC, 39%; DLCO, 67% of predicted value), an 84-year-old man with GOLD II disease (FEV1, 52% of predicted value; FEV1/FVC, 44%; RV/TLC, 62%; DLCO, 47% of predicted value), and a 67-year-old woman with GOLD III disease (FEV1, 33% of predicted value; FEV1/FVC, 39%; RV/TLC, 72%; DLCO, 28% of predicted value). First row: 3He MR images coregistered with 1H MR images (grayscale) show static ventilation (blue areas). Second row: 3He MR imaging ADC maps show that the ex-smokers with more advanced COPD (GOLD II/ III disease) have elevated ADC values. Third row: CT attenuation masks show areas of less than 2950 HU (yellow areas). Fourth row: PRMs show areas of healthy tissue (green), gas trapping (yellow), and emphysema (red). Permission has been obtained from Radiology [35] disease at the alveolar level, helping to the early diagnosis and intervention.
Texture analysis
In the statement of Fleischner society on CT-definable subtypes of COPD, emphysema is classified into three subtypes, centrilobular emphysema, pan-lobular emphysema and para-septal emphysema [12] . The different subtypes of emphysema and different HRCT phenotypes of COPD have different clinical managements; the classification of subtypes and phenotypes is very important. Automated texture-based quantification of emphysema subtypes has been successfully implemented via supervised learning of these three emphysema subtypes. Yang et al. extracted three types of texture features, including frequency histograms of textons, soft histograms of intensities and difference of Gaussian (DoG) responses, and joint histograms of local binary patterns (LBP) and intensities; and demonstrated that unsupervised learning on a large heterogeneous database of CT scans can generate texture prototypes that are visually homogeneous and distinct, reproducible across subjects, and capable of predicting the three standard radiological subtypes accurately, which open the way to new interpretations of lung CT scans with finer subtyping of emphysema [39] . It has been reported that hybrid airway segmentation using multi-scale tubular structure filters and texture analysis on 3D chest CT scans has been performed successfully in the Korean Obstructive Lung Disease (KOLD) Cohort [40] . The method limitations were higher false-positive rates than those of the other methods and risk of leakage. In future studies, application of a convolutional neural network will help overcome these shortcomings [40] .
Conclusion
Imaging plays a great role in the assessment of COPD, which provides the detailed anatomical, quantitative and functional information, illustrates the regional heterogeneity and spatial distribution, as well as provides microstructural assessment at the alveolar level. Especially, ATI, PRM, gas exchange and texture analysis facilitate the early diagnosis, phenotype classification, severity and therapeutic effect evaluation in the near future.
